Allergan's Largest Shareholder Sells Most of Holdings - Presented by: The Aol. On Network

One of Allergan's top shareholders has sold nearly all of its holdings in the stock, leaving the Botox maker without the support of a large and long-term investor as it tries to stave off a $53 billion hostile takeover by Valeant Pharmaceuticals International. Maureen Farrell joins MoneyBeat. Photo: Getty Images.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 14.38 0.39 ▼ 2.64%
PFE $ 33.78 0.98 ▲ 2.99%
VRX $ 36.99 4.34 ▲ 13.29%
FCX $ 12.095 1.46 ▼ 10.74%
AAPL $ 95.32 1.68 ▲ 1.79%
FTR $ 5.15 0.29 ▼ 5.33%
F $ 13.445 0.18 ▼ 1.28%
TVIX $ 3.67 0.27 ▲ 7.94%

As of 5/3/2016, 02:41 PM